C Patrick Reynolds

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Multiple Myeloma

Endoplasmic Reticulum

Top Venues

Cancer research

Science translational medicine

Molecular cancer therapeutics

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shawn J Macha, Balakrishna Koneru, Trevor A Burrow, Charles Zhu, Dzmitry Savitski, Rakhshanda L Rahman, Catherine A Ronaghan, Jonas Nance, Kristyn McCoy, Cody Eslinger, C Patrick Reynolds
Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function. Cancer research 82 (18) (2022)
Balakrishna Koneru, Ahsan S Farooqi, Thinh Hoang Nguyen, Wan Hsi Chen, Ashly Hindle, Cody Eslinger, Monish Ram Makena, Trevor A Burrow, Joanne Wilson, Aaron Smith, Venkatesh Pilla Reddy, Elaine B Cadogan, Stephen T Durant, C Patrick Reynolds
ALT neuroblastoma chemoresistance due to telomere dysfunction-induced ATM activation is reversible with ATM inhibitor AZD0156. Science translational medicine 13 (607) (2021)
Balakrishna Koneru, Gonzalo Lopez, Ahsan Farooqi, Karina L Conkrite, Thinh H Nguyen, Shawn J Macha, Apexa Modi, Jo Lynne Rokita, Eduardo Urias, Ashly Hindle, Heather Davidson, Kristyn Mccoy, Jonas Nance, Vanda Yazdani, Meredith S Irwin, Shengping Yang, David A Wheeler, John M Maris, Sharon J Diskin, C Patrick Reynolds
Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma. Cancer research 80 (12) (2020)
Timothy L Lochmann, Krista M Powell, Jungoh Ham, Konstantinos V Floros, Daniel A R Heisey, Richard I J Kurupi, Marissa L Calbert, Maninderjit S Ghotra, Patricia Greninger, Mikhail G Dozmorov, Madhu Gowda, Andrew J Souers, C Patrick Reynolds, Cyril H Benes, Anthony C Faber
Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Science translational medicine 10 (441) (2019)
Thinh H Nguyen, Balakrishna Koneru, Sung-Jen Wei, Wan Hsi Chen, Monish Ram Makena, Eduardo Urias, Min H Kang, C Patrick Reynolds
Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models. Molecular cancer therapeutics 18 (12) (2019)
Monish R Makena, Hwang Eui Cho, Thinh H Nguyen, Balakrishna Koneru, Dattesh U Verlekar, Ashly Hindle, Min H Kang, C Patrick Reynolds
Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines. Pediatric blood & cancer 65 (12) (2018)
Lluis Lopez-Barcons, Barry J Maurer, Min H Kang, C Patrick Reynolds
P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models. International journal of cancer 141 (2) (2017)